Physician profile
Benjamin Elder
NPI 1194841015
$1,019.02
in general payments reported to CMS, 2019-2025
17 companies · $383 in 2025
The $383 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.63 · 2020: $45.38 · 2021: $164 · 2022: $46.68 · 2023: $132 · 2024: $233 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $175.99 | 2025 | Vital |
| Supernus Pharmaceuticals, INC. | $154.71 | 2023-2025 | Qelbree, Qelbree |
| Corium, LLC | $141.33 | 2021-2025 | Azstarys |
| Glaxosmithkline, LLC. | $76.13 | 2021-2024 | Bexsero |
| Sanofi-Aventis U.S. LLC | $67.03 | 2024 | |
| Pfizer INC. | $49.78 | 2019-2024 | |
| Verrica Pharmaceuticals INC. | $48.47 | 2024 | Ycanth |
| Takeda Pharmaceuticals U.S.A., INC. | $47.82 | 2021 | |
| Tris Pharma INC | $45.74 | 2021-2025 | Dyanavel Xr |
| Cranial Technologies, INC | $44.17 | 2023 | Doc Band |
| Ultragenyx Pharmaceutical INC. | $39.81 | 2020-2023 | |
| Astrazeneca Pharmaceuticals Lp | $37.86 | 2021-2023 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $30.65 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $19.42 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $15.29 | 2025 | Enflonsia, Gardasil 9 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $13.14 | 2021 | |
| Neos Therapeutics, Lp | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.